Drug industry antitrust act. Hearings before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty seventh Congress, first [ second] session, pursuant to S. Res. 52 on S. 1552, a bill to amend and supplement the antitrust laws, with respect to the manufacture and distribution of drugs, and for other purposes. Part 5

Volumes:

There are no volumes